Head neck cancer (HNC) is generally treated with a multimodality approach. Loco-regional-distant control is often worst, due to the advantage stage disease at diagnosis and the optimal treatment option remains an unresolved issue. Metronomic chemotherapy (MCHT) is an emerging therapeutic option in clinical oncology and it may prove useful in HNC patients.
Metronomic chemotherapy in head and neck cancer / DE FELICE, Francesca; Benevento, Ilaria; Musella, Angela; Musio, Daniela; Tombolini, Vincenzo. - In: CANCER LETTERS. - ISSN 0304-3835. - STAMPA. - 400:(2017), pp. 219-222. [10.1016/j.canlet.2016.10.047]
Metronomic chemotherapy in head and neck cancer
DE FELICE, FRANCESCA
Primo
;BENEVENTO, ILARIASecondo
;MUSELLA, ANGELA;TOMBOLINI, VincenzoUltimo
2017
Abstract
Head neck cancer (HNC) is generally treated with a multimodality approach. Loco-regional-distant control is often worst, due to the advantage stage disease at diagnosis and the optimal treatment option remains an unresolved issue. Metronomic chemotherapy (MCHT) is an emerging therapeutic option in clinical oncology and it may prove useful in HNC patients.File allegati a questo prodotto
| File | Dimensione | Formato | |
|---|---|---|---|
|
De Felice_Metronomic_2017.pdf
solo gestori archivio
Tipologia:
Versione editoriale (versione pubblicata con il layout dell'editore)
Licenza:
Tutti i diritti riservati (All rights reserved)
Dimensione
205.56 kB
Formato
Adobe PDF
|
205.56 kB | Adobe PDF | Contatta l'autore |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
